Article info

Download PDFPDF
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations

Authors

  • M A Dentener aDepartment of Pulmonology and Surgery, Maastricht University, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), 6202 AZ Maastricht, The Netherlands, bDepartment of Immunology and Cell Biology, Instituto di Ricerche Farmacologiche Mario Negri, Milan and Department of Biotechnology, Section of General Pathology, University of Brescia, Italy PubMed articlesGoogle scholar articles
  • E C Creutzberg aDepartment of Pulmonology and Surgery, Maastricht University, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), 6202 AZ Maastricht, The Netherlands, bDepartment of Immunology and Cell Biology, Instituto di Ricerche Farmacologiche Mario Negri, Milan and Department of Biotechnology, Section of General Pathology, University of Brescia, Italy PubMed articlesGoogle scholar articles
  • A M W J Schols aDepartment of Pulmonology and Surgery, Maastricht University, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), 6202 AZ Maastricht, The Netherlands, bDepartment of Immunology and Cell Biology, Instituto di Ricerche Farmacologiche Mario Negri, Milan and Department of Biotechnology, Section of General Pathology, University of Brescia, Italy PubMed articlesGoogle scholar articles
  • A Mantovani aDepartment of Pulmonology and Surgery, Maastricht University, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), 6202 AZ Maastricht, The Netherlands, bDepartment of Immunology and Cell Biology, Instituto di Ricerche Farmacologiche Mario Negri, Milan and Department of Biotechnology, Section of General Pathology, University of Brescia, Italy PubMed articlesGoogle scholar articles
  • C van‘t Veer aDepartment of Pulmonology and Surgery, Maastricht University, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), 6202 AZ Maastricht, The Netherlands, bDepartment of Immunology and Cell Biology, Instituto di Ricerche Farmacologiche Mario Negri, Milan and Department of Biotechnology, Section of General Pathology, University of Brescia, Italy PubMed articlesGoogle scholar articles
  • W A Buurman aDepartment of Pulmonology and Surgery, Maastricht University, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), 6202 AZ Maastricht, The Netherlands, bDepartment of Immunology and Cell Biology, Instituto di Ricerche Farmacologiche Mario Negri, Milan and Department of Biotechnology, Section of General Pathology, University of Brescia, Italy PubMed articlesGoogle scholar articles
  • E F M Wouters aDepartment of Pulmonology and Surgery, Maastricht University, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), 6202 AZ Maastricht, The Netherlands, bDepartment of Immunology and Cell Biology, Instituto di Ricerche Farmacologiche Mario Negri, Milan and Department of Biotechnology, Section of General Pathology, University of Brescia, Italy PubMed articlesGoogle scholar articles
  1. Dr M A DentenerMieke.Dentener{at}pul.unimaas.nl
View Full Text

Citation

Dentener MA, Creutzberg EC, Schols AMWJ, et al
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations

Publication history

  • Received September 27, 2000
  • Revision requested December 14, 2000
  • Revised April 19, 2001
  • Accepted June 8, 2001
  • First published September 1, 2001.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.